Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
Molecular Diagnostics
Consumer genetic testing may misrepresent breast cancer risk: Study
Women are being told they are at high risk of breast cancer from consumer genetic test results which do not take family history into account, say researchers.
September 21, 2023
Rome Therapeutics raises $72M in series B financing
Biotech company Rome Therapeutics has raised a further $72 million in financing to develop medicines for autoimmune diseases and continue its exploration of the “dark genome.”
September 20, 2023
Polygenic risk scores from multi-ancestry GWASs more accurate in diverse groups: Study
Polygenic risk scores (PRS) derived from multi-ancestry genome-wide association studies (GWASs) outperform PRSs based on single-ancestry GWASs in underrepresented populations, new research shows.
September 21, 2023
Researchers develop signature for scoring thyroid cancers
A team led by researchers at Vanderbilt University Medical Center has developed a signature for thyroid cancer aggressiveness that incorporates immune and other microenvironment features through multiomic analyses.
September 20, 2023
Broken String Biosciences raises $15M in series A financing round
Broken String Biosciences has closed a $15 million series A financing round.
September 19, 2023
Myriad Genetics, Memorial Sloan Kettering collaborate on MRD testing for breast cancer
Myriad Genetics is collaborating with Memorial Sloan Kettering Cancer Center to study the use of Myriad's minimal residual disease testing platform in predicting breast cancer treatment response.
September 18, 2023
Electronic DNA nanoballs detection enables fast, accurate, cheap pathogen detection
Electronic detection of DNA nanoballs could enable fast, accurate, and cheap identification of pathogens, according to a paper published in
Science Advances
.
September 18, 2023
Castle Biosciences Pittsburgh lab receives N.Y. state permit
Castle Biosciences has received a clinical laboratory permit from the New York State Department of Health for its Pittsburgh laboratory.
September 13, 2023
Agilent to sell Resolution Bioscience to Exact Sciences
Agilent Technologies has announced that it is selling Resolution Bioscience, its cancer testing business, to Exact Sciences for an undisclosed sum.
September 12, 2023
Identification of hundreds of blood pressure genes lays foundation for hypertension drugs
Researchers have found hundreds of genes that may affect blood pressure, setting the stage for further studies that could inform the development of new treatments for hypertension.
September 12, 2023
Illumina names new CEO
Illumina has appointed Agilent Technologies’ Senior Vice President Jacob Thaysen as CEO, effective September 25.
September 8, 2023
Actome outlines sequencing expansion plans as EU funding kicks in
Actome has outlined how funding from the European Innovation Council (EIC) will support work to adapt its technology to enable the measurement of “50 to 100 antibodies at the same time in a single cell.”
September 7, 2023
Page 1 of 187
Next Page